表紙
市場調查報告書
商品編碼
1081023

白蛋白市場 - 全球產業分析,規模,佔有率,成長,趨勢,預測(2021年∼2031年)

Albumin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

出版日期: | 出版商: Transparency Market Research | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球白蛋白市場相關調查,提供市場概要,以及2021年∼2031年的預測,各產品,用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 假設與調查手法

第3章 摘要整理:全球白蛋白市場

第4章 市場概要

  • 簡介
  • 概要
  • 市場動態
  • 全球白蛋白市場分析與預測,2017年∼2031年

第5章 重要的洞察

第6章 全球白蛋白市場分析與預測,各產品

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測,各產品,2017年∼2031年
    • 人血清白蛋白
    • 重組白蛋白
  • 市場魅力分析

第7章 全球白蛋白市場分析與預測,各用途

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測,各用途,2017年∼2031年
    • 人血清白蛋白的用途
    • 重組白蛋白的用途

第8章 全球白蛋白市場分析與預測,各終端用戶

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測,各終端用戶,2017∼2031年
    • 製藥公司及生物科技企業
    • 研究機關
    • 其他
  • 市場魅力分析

第9章 全球白蛋白市場分析與預測,各地區

  • 主要調查結果
  • 市場價值預測,各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第10章 北美的白蛋白市場分析與預測

第11章 歐洲的白蛋白市場分析與預測

第12章 亞太地區的白蛋白市場分析與預測

第13章 南美的白蛋白市場分析與預測

第14章 中東·非洲的白蛋白市場分析與預測

第15章 競爭情形

  • 市場參與企業-競爭矩陣
  • 市場佔有率分析,各企業,2020年
  • 企業簡介
    • Albumedix A/S
    • Albumin Therapeutics, LLC
    • Biotest AG
    • CSL Behring LLC
    • Grifols International, SA
    • HiMedia Laboratories Pvt. Ltd.
    • InVitria
    • Medxbio Pte Ltd.
    • Octapharma AG
    • RayBiotech, Inc.
    • Seracare Life Sciences(LGC)
    • Sigma-Aldrich Co.(Merck KGaA)
    • Takeda Pharmaceutical Company Limited(Shire)
目錄
Product Code: TMRGL84628

Scope of the Report

TMR's report on the global albumin market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global albumin market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global albumin market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global albumin market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global albumin market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global albumin market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global albumin market.

The report delves into the competitive landscape of the global albumin market. Key players operating in the global albumin market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global albumin market that have been profiled in this report.

Key Questions Answered:

  • What is the scope of growth of product companies in the global albumin market?
  • What will be the Y-o-Y growth of the global albumin market between 2017 and 2031?
  • What is the influence of changing trends in technologies on the global albumin market?
  • Will Asia Pacific be the most profitable market for albumin providers?
  • Which factors are anticipated to hamper the growth of the global albumin market during the forecast period?
  • Which are the leading companies in the global albumin market?

Research Methodology

TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global albumin market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global albumin market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the albumin market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the albumin market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global albumin market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global albumin market more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Albumin Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Albumin Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
  • 5.2. Regulatory Scenario by Key Countries
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Albumin Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Human Serum Albumin
    • 6.3.2. Recombinant Albumin
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Albumin Market Analysis and Forecasts, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Human Serum Albumin Applications
      • 7.3.1.1. Drug Formulation
      • 7.3.1.2. Drug Delivery
      • 7.3.1.3. Vaccines
      • 7.3.1.4. Medical Device Coating
      • 7.3.1.5. Culture Media & Stabilizers
      • 7.3.1.6. Diagnostics
      • 7.3.1.7. In Vitro Fertilization
    • 7.3.2. Recombinant Albumin Applications
      • 7.3.2.1. Drug Formulation
      • 7.3.2.2. Drug Delivery
      • 7.3.2.3. Vaccines
      • 7.3.2.4. Medical Device Coating
      • 7.3.2.5. Culture Media & Stabilizers
      • 7.3.2.6. Diagnostics
      • 7.3.2.7. In Vitro Fertilization

8. Global Albumin Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Pharmaceutical & Biotechnology Companies
    • 8.3.2. Research Institutes
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Albumin Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa

10. North America Albumin Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Human Serum Albumin
    • 10.2.2. Recombinant Albumin
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Human Serum Albumin Applications
      • 10.3.1.1. Drug Formulation
      • 10.3.1.2. Drug Delivery
      • 10.3.1.3. Vaccines
      • 10.3.1.4. Medical Device Coating
      • 10.3.1.5. Culture Media & Stabilizers
      • 10.3.1.6. Diagnostics
      • 10.3.1.7. In Vitro Fertilization
    • 10.3.2. Recombinant Albumin Applications
      • 10.3.2.1. Drug Formulation
      • 10.3.2.2. Drug Delivery
      • 10.3.2.3. Vaccines
      • 10.3.2.4. Medical Device Coating
      • 10.3.2.5. Culture Media & Stabilizers
      • 10.3.2.6. Diagnostics
      • 10.3.2.7. In Vitro Fertilization
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. Research Institutes
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Albumin Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Human Serum Albumin
    • 11.2.2. Recombinant Albumin
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Human Serum Albumin Applications
      • 11.3.1.1. Drug Formulation
      • 11.3.1.2. Drug Delivery
      • 11.3.1.3. Vaccines
      • 11.3.1.4. Medical Device Coating
      • 11.3.1.5. Culture Media & Stabilizers
      • 11.3.1.6. Diagnostics
      • 11.3.1.7. In Vitro Fertilization
    • 11.3.2. Recombinant Albumin Applications
      • 11.3.2.1. Drug Formulation
      • 11.3.2.2. Drug Delivery
      • 11.3.2.3. Vaccines
      • 11.3.2.4. Medical Device Coating
      • 11.3.2.5. Culture Media & Stabilizers
      • 11.3.2.6. Diagnostics
      • 11.3.2.7. In Vitro Fertilization
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Pharmaceutical & Biotechnology Companies
    • 11.4.2. Research Institutes
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By End-user
    • 11.6.3. By Country/Sub-region

12. Asia Pacific Albumin Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Human Serum Albumin
    • 12.2.2. Recombinant Albumin
  • 12.3. Market Value Forecast by Application, 2017-2031
    • 12.3.1. Human Serum Albumin Applications
      • 12.3.1.1. Drug Formulation
      • 12.3.1.2. Drug Delivery
      • 12.3.1.3. Vaccines
      • 12.3.1.4. Medical Device Coating
      • 12.3.1.5. Culture Media & Stabilizers
      • 12.3.1.6. Diagnostics
      • 12.3.1.7. In Vitro Fertilization
    • 12.3.2. Recombinant Albumin Applications
      • 12.3.2.1. Drug Formulation
      • 12.3.2.2. Drug Delivery
      • 12.3.2.3. Vaccines
      • 12.3.2.4. Medical Device Coating
      • 12.3.2.5. Culture Media & Stabilizers
      • 12.3.2.6. Diagnostics
      • 12.3.2.7. In Vitro Fertilization
  • 12.4. Market Value Forecast, by Product, 2017-2031
    • 12.4.1. Pharmaceutical & Biotechnology Companies
    • 12.4.2. Research Institutes
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. South Korea
    • 12.5.4. India
    • 12.5.5. Australia & New Zealand
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Albumin Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Human Serum Albumin
    • 13.2.2. Recombinant Albumin
  • 13.3. Market Value Forecast by Application, 2017-2031
    • 13.3.1. Human Serum Albumin Applications
      • 13.3.1.1. Drug Formulation
      • 13.3.1.2. Drug Delivery
      • 13.3.1.3. Vaccines
      • 13.3.1.4. Medical Device Coating
      • 13.3.1.5. Culture Media & Stabilizers
      • 13.3.1.6. Diagnostics
      • 13.3.1.7. In Vitro Fertilization
    • 13.3.2. Recombinant Albumin Applications
      • 13.3.2.1. Drug Formulation
    • 13.3.3. Drug Delivery
      • 13.3.3.1. Vaccines
      • 13.3.3.2. Medical Device Coating
      • 13.3.3.3. Culture Media & Stabilizers
      • 13.3.3.4. Diagnostics
      • 13.3.3.5. In Vitro Fertilization
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Pharmaceutical & Biotechnology Companies
    • 13.4.2. Research Institutes
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Albumin Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Human Serum Albumin
    • 14.2.2. Recombinant Albumin
  • 14.3. Market Value Forecast, by End-user, 2017-2031
    • 14.3.1. Pharmaceutical & Biotechnology Companies
    • 14.3.2. Research Institutes
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.4.1. GCC Countries
    • 14.4.2. South Africa
    • 14.4.3. Rest of Middle East & Africa
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Product
    • 14.5.2. By Application
    • 14.5.3. By End-user
    • 14.5.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2020
  • 15.3. Company Profiles
    • 15.3.1. Albumedix A/S
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Financial Analysis
      • 15.3.1.3. Growth Strategies
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. Albumin Therapeutics, LLC
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Financial Analysis
      • 15.3.2.3. Growth Strategies
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. Biotest AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Financial Analysis
      • 15.3.3.3. Growth Strategies
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. CSL Behring LLC
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Financial Analysis
      • 15.3.4.3. Growth Strategies
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. Grifols International, S.A.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Financial Analysis
      • 15.3.5.3. Growth Strategies
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. HiMedia Laboratories Pvt. Ltd.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Financial Analysis
      • 15.3.6.3. Growth Strategies
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. InVitria
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Financial Analysis
      • 15.3.7.3. Growth Strategies
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Medxbio Pte Ltd.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Financial Analysis
      • 15.3.8.3. Growth Strategies
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Octapharma AG
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Financial Analysis
      • 15.3.9.3. Growth Strategies
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. RayBiotech, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Financial Analysis
      • 15.3.10.3. Growth Strategies
      • 15.3.10.4. SWOT Analysis
    • 15.3.11. Seracare Life Sciences (LGC)
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Financial Analysis
      • 15.3.11.3. Growth Strategies
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. SWOT Analysis
    • 15.3.12. Sigma-Aldrich Co. (Merck KGaA)
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Financial Analysis
      • 15.3.12.3. Growth Strategies
      • 15.3.12.4. SWOT Analysis
    • 15.3.13. Takeda Pharmaceutical Company Limited (Shire)
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Financial Analysis
      • 15.3.13.3. Growth Strategies
      • 15.3.13.4. SWOT Analysis

List of Tables

  • Table 01: Global Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017-2031
  • Table 04: Global Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 05: Global Albumin Market Value (US$ Mn), Forecast, 2017-2031
  • Table 06: Global Albumin Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Albumin Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 09: North America Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017-2031
  • Table 11: North America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 12: North America Albumin Market Value (US$ Mn), Forecast, by End-user, 2017-2031
  • Table 13: Europe Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 14: Europe Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Europe Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Europe Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017-2031
  • Table 17: Europe Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 18: Europe Albumin Market Value (US$ Mn), Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 20: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 21: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 22: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017-2031
  • Table 23: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 24: Asia Pacific Albumin Market Value (US$ Mn), Forecast, 2017-2031
  • Table 25: Latin America Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 26: Latin America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Latin America Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 28: Latin America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017-2031
  • Table 29: Latin America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 30: Latin America Albumin Market Value (US$ Mn), Forecast, 2017-2031
  • Table 31: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 32: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 33: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 34: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017-2031
  • Table 35: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 36: Middle East & Africa Albumin Market Value (US$ Mn), Forecast, 2017-2031

List of Figures

  • Figure 01: Global Albumin market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Albumin market Value Share, by Product Type, 2020
  • Figure 03: Global Albumin market Value Share, by End-user, 2020
  • Figure 04: Global Albumin market Value Share, by Region, 2020
  • Figure 05: Global Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 06: Global Albumin Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 07: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin, 2017-2031
  • Figure 08: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin, 2017-2031
  • Figure 09: Global Albumin Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 10: Global Albumin Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 11: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin Applications, 2017-2031
  • Figure 12: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin Applications, 2017-2031
  • Figure 13: Global Albumin Market, by End-user, 2020 and 2031
  • Figure 14: Global Albumin Market, by End-user, 2021-2031
  • Figure 15: Global Albumin Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2031
  • Figure 16: Global Albumin Market (US$ Mn), by Research Institutes, 2017-2031
  • Figure 17: Global Albumin Market (US$ Mn), by Others, 2017-2031
  • Figure 18: Global Albumin Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 19: Global Albumin Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 20: North America Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 21: North America Albumin Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 22: North America Albumin Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 23: North America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 24: North America Albumin Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 25: North America Albumin Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 26: North America Albumin Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 27: North America Albumin Market, by End-user, 2020 and 2031
  • Figure 28: North America Albumin Market, by End-user, 2021-2031
  • Figure 29: Europe Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
  • Figure 30: Europe Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 31: Europe Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 32: Europe Albumin Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 33: Europe Albumin Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 34: Europe Albumin Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 35: Europe Albumin Market, by End-user, 2020 and 2031
  • Figure 36: Europe Albumin Market, by End-user, 2021-2031
  • Figure 37: Asia Pacific Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
  • Figure 38: Asia Pacific Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 39: Asia Pacific Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 40: Asia Pacific Albumin Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 41: Asia Pacific Albumin Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 42: Asia Pacific Albumin Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 43: Asia Pacific Albumin Market, by End-user, 2020 and 2031
  • Figure 44: Asia Pacific Albumin Market, by End-user, 2021-2031
  • Figure 45: Latin America Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
  • Figure 46: Latin America Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 47: Latin America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 48: Latin America Albumin Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 49: Latin America Albumin Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 50: Latin America Albumin Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 51: Latin America Albumin Market, by End-user, 2020 and 2031
  • Figure 52: Latin America Albumin Market, by End-user, 2021-2031
  • Figure 53: Middle East & Africa Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 54: Middle East & Africa Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
  • Figure 55: Middle East & Africa Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 56: Middle East & Africa Albumin Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 57: Middle East & Africa Albumin Market Attractiveness Analysis, by Product Type, 2021-2031
  • Figure 58: Middle East & Africa Albumin Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 59: Middle East & Africa Albumin Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 60: Middle East & Africa Albumin Market, by End-user, 2020 and 2031
  • Figure 61: Middle East & Africa Albumin Market, by End-user, 2021-2031
  • Figure 62: Global Albumin Market Share, by Company, 2021